Understanding the consequences of psychedelics on human brain networks is significant to unlocking their therapeutic mechanisms. In human beings, over the roughly 6 hour length of motion, psilocybin boosts glutamate signalling and glucose metabolism19,20,21, broadly decreases the strength of